Investor Alert

New York Markets After Hours

Dec. 11, 2019, 3:04 a.m. EST

Immortalized cell line market to witness immense growth as researchers seek treatment for cancer

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Dec 11, 2019 (Heraldkeepers) -- Immortalized Cell Line Market Overview

Immortalized cell lines have wide application in the field of healthcare and life science. Increasing adoption of cell line system in cancer therapy, increasing research and development activities and growth in biotechnology sector drive the global immortalized cell line market. The global immortalized cell line market is expected to grow at a CAGR of 9.30% is anticipated to reach USD 4,105.62 million during 2017-2023.

Demand for organ transplant has been on the rise but there is a scarcity in the availability of organs. For instance, according to the American Transplant Foundation, as of 2019, nearly 114,000 people are waiting on the organ transplant list in the U.S. alone and nearly 20 people die every day due to the lack of viable organs. Researchers have therefore been working to develop artificial biological cells which would in turn drive the immortalized cell line market.

Moreover, the rising incidence of cancer and urgent need to find effective treatment for the various types of cancer, are factors that will potentially boost the immortalized cell line market. Researchers and scientists often study the cells from an extracted tumor to understand what are the conditions that are triggering the growth of cancerous cells and develop means through which it can be ascertained how much cancer is in the body and predict how the cancer will behave and in what way it will respond to treatment.

The high cost of equipment and difficulty in stable cell line development can prove to be some of the obstacles in the growth path of immortalized cell line market but increased financial support provided by government and private entities would be suffice to overcome such hurdles and lead to future industry growth.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/751

Immortalized Cell Line Market Segmentation:

The immortalized cell line market has been segmented according to method, application, and end user.

According to method, immortalized cell line market is classified into virus hTERT expression, induction, inactivation of tumor suppression genes, and others.

By application, immortalized cell line market, is divided into drug discovery, diagnostics, tissue engineering and regenerative medicine, vaccine production, and others.

End user segmentation of immortalized cell line market includes Contract Research Organizations (CROs), pharmaceutical and biopharmaceutical companies, and research laboratories. The pharmaceutical and biopharmaceutical companies segment amassed a revenue of approximately USD 1,323.79 million in 2017.

Immortalized Cell Line Market Regional Analysis:

Regional segmentation of immortalized cell line market has been done on the basis of Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold a dominating position in the global immortalized cell line market owing to the presence of well-established pharmaceutical and biotechnology industry in the region as well as greater incidence of cancer, expansive research funding and increasing awareness about immortalized cell lines.

Europe immortalized cell line market size is anticipated to be second to that of the Americas during the forecast period. Robust government support, technology advancements in healthcare, and rising incidence of cancer would boost market growth in the region.

Asia-Pacific immortalized cell line market is anticipated to record fastest-growth due to the increasing expenditure by governments on enhancement of healthcare facilities. Expanding research for betterment of healthcare offerings and expansive patient population have attracted key players to shift their focus to the region which has helped Asia Pacific to register a market share of 17.8% in 2017.

Immortalized Cell Line Market Competitive Overview:

Some of the prominent players in the immortalized cell line market include Thermo Fisher Scientific, American Type Culture Collection Inc., Valneva, Sartorius AG, Lonza Group, AG, Merck KGaA (Germany), Selexis SA, WuXi App Tec, European Collection of Authenticated Cell Cultures, and Corning Incorporated.

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.